DNA Capital is an investment partnership founded in 2013 that makes multi-stage investments in the healthcare sector, from early stage companies to private equity. It belongs to one of the world's leading healthcare groups. The firm invests globally from offices in São Paulo, Brazil and San Francisco, California. Its mission is to invest in the best companies and founding teams in healthcare and to give them strategic value. The team is multidisciplinary, deeply rooted in healthcare, and passionate about finding and helping the best companies thrive.
| Investor | Type | Based in | Focus | AUM | Contacts |
|---|---|---|---|---|---|
| SEI Investments | Fund of Funds | Oaks | Multifamily · Industrial | $1.5T | 4 |
| Blackstone Group - Fund of Funds and Secondary | Fund of Funds | New York | Multifamily · Industrial · Core | $1.1T | 16 |
| New York Life Investment Management | Asset Manager | New York | Multifamily · Industrial · Co-investment | $740B | 5 |
| Brookfield Asset Management | Asset Manager | Toronto, Canada | Multifamily · Industrial · Opportunistic · Joint venture | $690B | 12 |
| KKR | Asset Manager | New York | Multifamily · Industrial · Core · Co-investment | $553B | 11 |
| Ares Management | Asset Manager | Los Angeles | Multifamily · Industrial · Core | $546B | 16 |
Filter the full list by property type, strategy, market and deal format.
